Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
By R. Mattick, J. Kimber, C. Breen, M. Davoli. Cochrane Database of Systematic Reviews, 2008
1,733 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/ea8690b37ee44bf4c52758e343567e6453a40965
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Luis Sordo
- L. Degenhardt
- G. Barrio
- M. Bravo
- I. Indave
- L. Wiessing
- M. Ferri
- R. Pastor-Barriuso
Citations in the corpus
- Screening, Brief Intervention, and Referral to Treatment (SBIRT) (2007, unknown): “A Cochrane Review meta-analysis of 13 randomized clinical trials concluded that buprenorphine is an effective intervention for use in the maintenance treatment of heroin dependence (79).”
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies (2017, methodology): “…study design and was based on a “star system” score approach, 16 including a general appraisal of external and internal validity and of the biases relevant to cohort studies, plus an ad hoc assessment of reporting for studies on mortality during and after opioid substitution treatment (appendix 3).”
- Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. (2007, unknown): “(64,814) 21 (comparison group$ or control group$).”
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality (2018, unknown): “MMT 1817 (10) 594 (5) 691 (49) 233 (10) 55 (7) 244 (28)”